首页|HOXB9、E-cadherin在子宫内膜癌组织中的表达及其与术后淋巴结转移的关系

HOXB9、E-cadherin在子宫内膜癌组织中的表达及其与术后淋巴结转移的关系

扫码查看
目的 探究Homeobox B9(HOXB9)、E-钙黏蛋白(E-cadherin)在子宫内膜癌组织中的表达及其与术后淋巴结转移的关系.方法 选取行手术治疗的76 例子宫内膜癌患者作为观察组,另选取同期接受子宫肌瘤切除术的 32 例正常子宫内膜组织作为对照.根据子宫内膜癌患者术后1 年的淋巴结转移情况将观察组中 76 例患者分为淋巴结转移组(n=30)和淋巴结未转移组(n=46).采用免疫组织化学染色法检测组织中HOXB9、E-cadherin的表达,分析其与术后淋巴结转移的关系.结果 子宫内膜癌组织HOXB9 的阳性表达率(68.42%)高于正常子宫内膜组织(34.38%)(P<0.05),子宫内膜癌组织E-cadherin的阳性表达率(30.26%)低于正常子宫内膜组织(71.88%)(P<0.05).淋巴结转移患者HOXB9 的阳性表达率(90.00%)高于淋巴结未转移患者(54.35%)(P<0.05),淋巴结转移患者的E-cadherin阳性表达率(16.67%)低于淋巴结未转移患者(39.13%)(P<0.05).淋巴结转移组与淋巴结未转移组的患者绝经情况差异无统计学意义(P>0.05),两组患者的FIGO分期、病灶直径、浸润深度差异有统计学意义(P<0.05).多因素Logistic回归结果显示HOXB9(OR=1.559,95%CI:1.124~1.905)、E-cadherin(OR=1.729,95%CI:1.272~2.350)、FIGO分期(OR=1.427,95%CI:1.040~1.860)、病灶直径(OR=1.883,95%CI:1.376~2.562)、浸润深度(OR=1.974,95%CI:1.562~2.709)均是患者术后淋巴结转移的危险因素(P<0.05).结论 子宫内膜癌患者的HOXB9 表达上调、E-cadherin表达下调,且其表达的改变会增加术后淋巴结转移的风险,也是导致子宫内膜癌患者术后预后不良的因素之一.
Expression of HOXB9 and E-cadherin in Endometrial Cancer Tissues and Its Correlation with Postoperative Lymph Node Metastasis
Objective To explore the expression of homeobox B9(HOXB9)and E-cadherin in endometrial cancer tissues and its correlation with postoperative lymph node metastasis,and to provide theoretical basis for the clinical treatment and progno-sis evaluation of endometrial cancer.Methods 76 patients with endometrial cancer who underwent surgical treatment were retro-spectively selected as the observation group,and another 32 patients underwent myomectomy were concurrently enrolled as the control group.The observation group was further classified into lymph node metastasis group(n=30)and non lymph node metasta-sis group(n=46)according to the lymph node metastasis status at postoperative1 year.Immunohistochemical staining was utilized to measure the expression of HOXB9 and E-cadherin in the collected tissues,then the correlation between the indicator expression and postoperative lymph node metastasis was explored.Results The positive expression of HOXB9 was 68.42%in cancer tis-sues,which was higher than 34.38%in normal tissues,and the positive expression of E-cadherin was 30.26%in cancer tissues,which was lower than71.88%in normal tissues,with statistical difference(all P<0.05).The positive expression of HOXB9 was 90.00%in lymph node metastasis group,which was higher than 54.35%in non lymph node metastasis group,and the positive expression of E-cadherin was 16.67%in lymph node metastasis group,which was lower than 39.13%in non lymph node metas-tasis group,with statistical difference(all P<0.05).No statistical difference was reported between lymph node metastasis group and non lymph node metastasis group in the menopausal status(P>0.05),whereas statistical difference was found in FIGO stag-ing,lesion diameter,and infiltration depth(P<0.05).Multivariate Logistic regression analysis denoted that HOXB9(OR=1.559,95%CI:1.124~1.905),E-cadherin(OR=1.729,95%CI:1.272~2.350),FIGO staging(OR=1.427,95%CI:1.040~1.860),lesion diameter(OR=1.883,95%CI:1.376~2.562)and depth of invasion(OR=1.974,95%CI:1.562~2.709)were all risk factors for postoperative lymph node metastasis in patients with endometrial cancer(P<0.05).Conclusion The HOXB9 expression is up-regulated and E-cadherin expression is down-regulated in patients with endometrial cancer,and the ab-normal change may increase the risk of postoperative lymph node metastasis,which is one of the factors leading to the poor progno-sis of patients with endometrial cancer after surgery.

HOXB9E-cadherinEndometrial cancerLymph node metastasis

史英、孙春丽、王晓明

展开 >

461000 河南科技大学附属许昌市中心医院

HOXB9 E-cadherin 子宫内膜癌 淋巴结转移

2024

实用癌症杂志
江西省肿瘤医院 江西省肿瘤研究所

实用癌症杂志

影响因子:1.241
ISSN:1001-5930
年,卷(期):2024.39(12)